Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension

E. Holtzman, T. Rosenthal, N. Stern, A. Knecht, A. Yaron

Research output: Contribution to journalArticlepeer-review

Abstract

The hypotensive response to captopril is described for 12 hypertensive patients, 7 of whom had renovascular hypertension. The drug was effective in lowering blood pressure. The few reversible adverse reactions that occurred included loss of the sense of taste in one patient and rash and fever in another. Three patients with renal failure showed deterioration of renal function during treatment, suggesting the advisability of treating such cases with lower dosages.

Original languageEnglish
Pages (from-to)597-602
Number of pages6
JournalIsrael Journal of Medical Sciences
Volume18
Issue number5
StatePublished - 1982
Externally publishedYes

Fingerprint

Dive into the research topics of 'Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension'. Together they form a unique fingerprint.

Cite this